Atorvastatin improves ovarian function and follicular reserve in rats with premature ovarian insufficiency
Reproductive BioMedicine Online · 2024
DOI: 10.1016/j.rbmo.2024.104324 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproductive BioMedicine Online, 2024. Verfasst von Parmis Notghi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of Science, Arak University, Arak, Iran. Hauptthemen laut MEDLINE: Primary Ovarian Insufficiency, Atorvastatin, Rats, Wistar, Ovarian Follicle. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben.
Abstract (Originalsprache)
RESEARCH QUESTION: Can atorvastatin, with its antioxidant, anti-inflammatory and anti-apoptotic properties, improve ovarian function and follicular reserve in rats with cyclophosphamide-induced premature ovarian insufficiency (POI)? DESIGN: In this experimental study, 24 adult female Wistar rats were divided into four groups: control; POI; POI + atorvastatin; and atorvastatin. After treatment with atorvastatin, serum concentrations of total antioxidant capacity, glutathione, malondialdehyde, FSH, oestradiol, anti-Müllerian hormone, tumour necrosis factor-alpha and interleukin-6 were evaluated. Additionally, mRNA and protein expression of Bax, Bcl-2 and VEGF-A; number of follicles; and total volume of the ovary, and volumes of the cortex and medulla were examined. RESULTS: The results showed that serum concentrations of total antioxidant capacity (P < 0.001), glutathione, oestradiol and anti-Müllerian hormone (P < 0.05); mRNA and protein expression of Bcl-2 and VEGF-A (P < 0.05); number of primordial and primary follicles (P < 0.001), and preantral and antral follicles (P < 0.01); and total volume of the ovary, and volume of the cortex (P < 0.05) increased significantly in the POI + atorvastatin group compared with the POI group. Serum concentrations of malondialdehyde, FSH, tumour necrosis factor-alpha and interleukin-6; and mRNA and protein expression of Bax decreased significantly in the POI + atorvastatin group compared with the POI group (P < 0.05). CONCLUSIONS: Atorvastatin reduces the detrimental effects of cyclophosphamide in the POI model significantly by reducing oxidative stress and pro-inflammatory cytokines; regulating the expression of Bax, Bcl-2 and VEGF-A; and improving ovarian function and follicular reserve.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Faculty of Science, Arak University, Arak, Iran.
- Department of Biology, Faculty of Science, Arak University, Arak, Iran. Electronic address: m-soleimani@araku.ac.ir.
Zitieren
APA
Notghi, P., Mehranjani, M. S., & Shariatzadeh, S. M. A. (2024). Atorvastatin improves ovarian function and follicular reserve in rats with premature ovarian insufficiency. Reproductive BioMedicine Online. https://doi.org/10.1016/j.rbmo.2024.104324
Vancouver
Notghi P, Mehranjani MS, Shariatzadeh SMA. Atorvastatin improves ovarian function and follicular reserve in rats with premature ovarian insufficiency. Reproductive BioMedicine Online. 2024. doi:10.1016/j.rbmo.2024.104324
BibTeX
@article{Notghi2024,
author = {Notghi, Parmis and Mehranjani, Malek Soleimani and Shariatzadeh, Seyed Mohammad Ali},
title = {Atorvastatin improves ovarian function and follicular reserve in rats with premature ovarian insufficiency},
journal = {Reproductive BioMedicine Online},
year = {2024},
doi = {10.1016/j.rbmo.2024.104324}
}
EUVIMED